Are metals dietary carcinogens?

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 443, Issue 1-2, 1999, Pages 157-181

  Rojas, Emilio ^a   Herrera, Luis A ^a   Poirier, Lionel A ^a   Ostrosky Wegman, Patricia ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Arsenic; Cadmium; Chromium; Environmental; Genotoxicity; Lead; Mercury; Nickel; Selenium; Tin; Vanadium; Zinc

Indexed keywords

ARSENIC; CADMIUM; CHROMIUM; LEAD; MERCURY; METAL; METAL DERIVATIVE; NICKEL; SELENIUM; TIN; VANADIUM; ZINC;

CARCINOGENICITY; EVOLUTION; EXPOSURE; FOOD CONTAMINATION; GENOTOXICITY; HUMAN; MUTAGENICITY; NUTRITION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 0033565750     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(99)00018-6     Document Type: Article

References (262)

1. L. Fishbein, A. Furt, M.A. Mehlman, Genotoxic and carcinogenic metals: environmental and occupational occurrence and exposure, Princenton Scientific Publishing, USA, 1987, pp. 339.
2. Zhu J., Koken H.M., Quignon F., Chelbi-Alix M.K., Degos L., Yi Wang Z., Chen Z., de The H. Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. Proc. Natl. Acad. Sci. 94:1997;3978-3983.
3. WHO, Selenium, IPCS, Environmental Health Criteria 58, World Health Organization, Geneva, 1987, p. 306.
4. WHO, Cadmio, IPCS, Environmental Health Criteria 135, World Health Organization, Geneva, 1992, p. 280.
5. WHO, Chromium, IPCS, Environmental Health Criteria 61, World Health Organization Geneva, 1988, p. 197.
6. WHO, Nickel, IPCS, Environmental Health Criteria 108, World Health Organization, Geneva, 1991, p. 383.
7. L. Fishbein, Bioavailability and interactions of metals: considerations, in: L. Fishbein, A. Furst, M.A. Mehlman (Eds.), Genotoxic and Carcinogenic Metals: Environmental and Occupational Occurrence and Exposure, Princenton Scientific Publishing, USA, 1987, pp. 245-264.
8. Goyer R.A. Nutrition and metal toxicity. Am. J. Clin. Nutr. 61:1995;646S-650S.
9. Peraza M.A., Ayala-Fierro F., Barber D.S., Casarez E., Rael L.T. Effects of micronutrients on metal toxicity. Environ. Health Perspect. 106:1998;203-216.
10. Carter D.E. Oxidation-reduction reactions of metal ions. Environ. Health Perspect. 103:1995;17-19.
11. Hart R.W., Turturro A. Dietary restrictions and cancer. Environ. Health Perspect. 105:1997;989-992.
12. Obata H., Sawada N., Isomura H., Mori M. Abnormal accumulation of copper in LEC rat liver induces expression of p53 and nuclear matrix-bound p21 (waf 1/cip 1). Carcinogenesis. 17:1996;2157-2161.
13. Walsh L.M., Sumner M.E., Keeney D.R. Occurrence and distribution of arsenic in soils and plants. Environ. Health Perspect. 19:1977;67-71.
14. WHO, Arsenic, IPCS, Environmental Health Criteria 18, World Health Organization Geneva, 1981, p. 174.
15. Kennedy V.S. Arsenic concentrations in some coexisting marine organisms from Newfoundland and Labrador. J. Fish. Res. Board Can. 33:1976;1388-1393.
16. Walkiw O., Douglas D.E. Health food supplements prepared from kelp - a source of elevated urinary arsenic. Clin. Toxicol. 8:1975;325-331.
17. Lunde G. Occurrence and transformation of arsenic in the marine environment. Environ. Health Perspect. 19:1977;47-52.
18. Noble A.C., Orr B.H., Cook W.B., Campbell J.L. Trace element analysis of wine by proton-induced X-ray fluorescence spectrometry. J. Agric. Food Chem. 24:1976;532-535.
19. Vega L., Gonsebatt M.E., Ostrosky-Wegman P. Aneugenic effect of sodium arsenite on human lymphocytes in vitro: an individual susceptibility effect detected. Mutat. Res. 334:1995;365-373.
20. Gonsebatt M.E., Vega L., Salazar A.M., Montero R., Guzmán P., Blas J., del Razo L.M., García-Vargas G., Albores A., Cebrián M.E., Kelsh M., Ostrosky-Wegman P. Cytogenetic effects in human exposure to arsenic. Mutat. Res. 386:1997;219-228.
21. Li J.H., Rossman T.G. Comutagenesis of sodium arsenite with ultraviolet radiation in Chinese hamster V79 cells. Biol. Metals. 4:1991;197-200.
22. Lee-Chen S.F., Yu C.T., Jan K.Y. Effect of arsenite on the DNA repair of UV-irradiated Chinese hamster ovary cells. Mutagenesis. 7:1992;51-55.
23. Salazar A.M., Ostrosky-Wegman P., Menéndez D., Miranda E., García-Carrancá A., Rojas E. Induction of p53 protein expression by sodium arsenite. Mutat. Res. 381:1997;259-265.
24. Rossman T.G. Enhancement of UV-mutagenesis by low concentrations of arsenite in E. coli. Mutat. Res. 91:1981;207-211.
25. Lee T.C., Oshimura M., Oshimura J.C. Comparison of arsenic-induced cell transformation, mutation and cytogenetic effects in Syriam hamster embryo cells in culture. Carcinogenesis. 6:1985;1421-1426.
26. Yang J.L., Chen M.F., Cheng-Wen W., Te-Chang L. Post-treatment with sodium arsenite alters the mutational spectrum induced by ultraviolet light irradiation in Chinese hamster ovary cells. Environ. Mol. Mutagen. 20:1992;156-164.
27. di Paolo J.A., Casto B.C. Quantitative studies of in vitro morphological transformation of Syriam hamster cells by inorganic metal salts. Cancer Res. 32:1979;1008-1013.
28. Lee-Chen S.F., Gurr J.R., Lin I.B., Jan K.Y. Arsenite enhances DNA strand breaks and cell killing of methyl methanesulofonate treated cells by inhibiting the excision of alkai-labile sites. Mutat. Res. 294:1993;21-28.
29. Hartmann A., Speit G. Comparative investigations of the genotoxic effects of metals in the single cells gel (SCG) assay and the sister chromatid exchange (SCE) test. Environ. Mol. Mutagen. 23:1994;299-305.
30. Li J.-H., Rossman T.G. Mechanism of comutagenesis of sodium arsenite with n-methyl-n-nit5rosourea. Biol. Trace Elem. Res. 21:1989;373-381.
31. Hartwig A. Current aspects in metal carcinogenicity. BioMetals. 8:1995;3-11.
32. Okui T., Fujiwara Y. Inhibition of human excision DNA repair by inorganic arsenic and the co-mutagenic effect in V79 chinese hamster cells. Mutat. Res. 172:1986;69-76.
33. Eastmon D.A., Tuker J.D. Kinetochore localization in micronucleated cytokinesis-blocked chinese hamster ovary cells: a new and rapid assay for identifying aneuploidy-inducing agents. Mutat. Res. 224:1989;517-525.
34. Dong J.-T., Luo X.-M. Effect of arsenic on DNA damage and repair in human fetal lung fibroblasts. Mutat. Res. DNA Repair. 315:1994;11-15.
35. Aposhian H.V., Aposhian M.M. Newer developments in arsenic toxicity. J. Am. Coll. Toxicol. 8:1989;1297-1305.
36. Lynn L.S., Shiung J.N., Gurr J.R., Jan K.Y. Arsenite stimulates poly(ADP-robosylation) by generation of nitric oxide. Free Radic. Biol. Med. 24:1998;442-449.
37. Hei T.K., Liu S.X., Waldren C. Mutagenicity of arsenic in mammalian cells: role of reactive oxygen species. Proc. Natl. Acad. Sci. U.S.A. 95:1998;8103-8107.
38. Chiou H.-Y., Hsueh Y.M., Liaw K.F., Horng S.F., Chiang M.H., Pu Y.S., Lin J.S., Huang C.H., Chen C.J. Incidence of internal cancers and ingested inorganic arsenic: a seven years follow up study in Taiwan. Cancer Res. 55:1995;1296-1330.
39. Chen C.-J., Chen C.W., Wu M.-M., Kuo T.-L. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br. J. Cancer. 66:1992;888-892.
40. Chen C.J., Wang C.J. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res. 50:1990;5470-5474.
41. Chen C.J., Chuang Y.C., Lin T.M., Wu H.Y. Malignant neoplasms amoung residents of a blackfoot disease endemic area in Taiwan: high arsenic artesian well water and cancers. Cancer Res. 45:1985;5895-5899.
42. IARC, Chromium and chromium compounds, in: Some Metals and Metallic Compounds, Lyons, International Agency for Research on Cancer, IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 23, 1980, pp. 205-323.
43. R.D. Davis, E.G. Coker, Cadmium in agriculture, with special reference to the utilisation of sewage studge on land, Medmemham, United Kingdown, Water Research Centre, Technical Report TR/139, 1980.
44. Meranger J.C., Subramanian K.S., Chalifoux C. Metals and other elements. Survey for cadmium, cobalt, chromium, copper, nickel, lead, zinc, calcium, and magnesium in Canadian drinking-water supplies. J. Assoc. Off. Anal. Chem. 64:1981;44-53.
45. Kjellström T., Borg K., Lind B. Cadmium in faeces as an estimator of daily cadmium intake in Sweden. Environ. Res. 15:1978;242-251.
46. Brennan R.J., Schiestl R.H. Cadmium is a inducer of oxidative stress in yeast. Mutat. Res. 356:1996;171-178.
47. E. Gebhart, T.G. Rossman, Mutagenicity, carcinogenicity, teratogenicity, in: E. Merian (Ed.), Metals and their Compounds in the Environment, 1991, pp. 617-640.
48. Misra R.R., Smith G.T., Waalkes M.P. Evaluation of the direct genotoxic potential of cadmium in four different rodent cell lines. Toxicology. 126:1998;103-114.
49. Saplakoglu U., Iscan M. Sister chromatid exchanges in human lymphocytes treated in vitro with cadmium in G(o) and S phase of their cell cycles. Mutat. Res. 412:1998;109-114.
50. Forni A. Comparison of chromosome aberrations and micronuclei in testing genotoxicity in humans. Toxicol. Lett. 72:1994;185-190.
51. Collins J.F., Brown J.P., Paianter P.R., Jamall I.S., Zeise L.A., Alexeeff G.V., Wade M.J., Siegel D.M., Wong J.J. On the carcinogenicity of cadmium by the oral route (see comments). Regul. Toxicol. Pharmacol. 16:1992;57-72.
52. Poirier L.A., Kasprzak K.S., Hoover K.L., Wenk M.L. Effects of calcium and magnesium acetates on the carcinogenicity of cadmium chloride in Wistar rats. Cancer Res. 43:1983;4575-4581.
53. Haddow A., Roe F.J.C., Dukes C.E., Mitchely B.C.V. Cadmium neoplasia: sarcomata at the site of injection of cadmium in rats and mice. Br. J. Cancer. 18:1964;667-673.
54. Gunn S.A., Gould T.C., Andreson W.A.D. Cadmium-induced interstitial cell tumors in rats and mice and their prevention by zinc. J. Natl. Cancer Inst. 31:1963;745-759.
55. Kazantzis G. Induction of sarcoma in the rat by cadmium sulfide pigment. Nature (London). 198:1963;1213-1214.
56. Oberdorster G., Cherian M.G.B. Correlation between cadmium-induced pulmonary carcinogenicity, metallothionein. Environ. Health Perspect. 102:1994;257-263.
57. Kazantzis G., Lam T.H., Sullivan K.R. Mortality of cadmium exposed workers. A five-year update. Scand. J. Work Environ. Health. 14:1988;220-223.
58. IARC, Lead and lead compounds, in: Overall Evaluations of Carcinogenicity an Updating of IARC Monographs, Vols. 1 to 42. Lyon, International Agency for Research on Cancer, IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Suppl. 7, 1987, pp. 230-232.
59. DeFlora S., Bagnasco M., Serra D., Zanacchi P. Genotoxicity of chromium compounds. A review. Mutat. Res. 238:1990;99-172.
60. Bianchi V., Levis A.G. Review of genetic effects and mechanisms of action of chromium compounds. Sci. Total Environ. 71:1988;351-355.
61. Lantzsch H., Gebel T. Genotoxicity of selected metal compounds in the SOS chromotest. Mutat. Res. 389:1997;191-197.
62. Biederman K.A., Landolph J.R. Induction of anchorage independence in human diploid foreskin fibroblasts by carcinogenic metal salts. Cancer Res. 47:1987;3815-3823.
63. Cohen M.D., Kargacin B., Klein C.B., Costa M. Mechanisms of chromium carcinogenicity and toxicity. Crit. Rev. Toxicol. 23:1993;255-281.
64. Sugiyama M., Tsuzuki K., Haramaki N. DNA single-strand breaks and cytotoxicity induced by sodium chromate (VI) in hydrogen peroxide-resistant cell lines. Mutat. Res. 299:1993;95-102.
65. Koppen G., Verschaeve L. The alkaline comet test on plant cells: a new genotoxicity test for DNA strand breaks in Vicia faba root cells. Mutat. Res. 360:1996;193-200.
66. Cupo D.Y., Wetterhahn K.E. Modification of chromium (VI)-induced DNA damage by glutathione and cytochromes p-450 in chicken embryo hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 82:1985;6755-6759.
67. Snow E.T., Xu L.S. Chromium (III) bound to DNA templates promotes increased polymerase processivity and decreased fidelity during replication in vitro. Biochemistry. 30:1991;11238-11245.
68. Snow E.T. A possible role for chromium (III) in genotoxicity. Environ. Health Perspect. 92:1991;75-81.
69. 4 with azide. Environ. Mutagen. 8:1986;717-725.
70. Bianchi V. Nucleotide pool unbalance induced in cultured cells by treatments with different chemicals. Toxicology. 25:1982;13-18.
71. Kohalmi S.E., Gattke M., McIntosh E.M., Kunz B.A. Mutational specificity of DNA precursor pool imbalances in yeast arising from deoxycytidylate deaminase deficiency or treatment with thymidylate. J. Mol. Biol. 220:1991;933-946.
72. Leonard A., Lauwerys R.R. Carcinogenicity and mutagenicity of chromium. Mutat. Res. 76:1980;227-239.
73. Imreh S.T., Radulescu D. Cytogenic effects of chromium in vivo and in vitro. Mutat. Res. 97:1982;192-193.
74. DeFlora S., Camoirano A., Bagnasco M., Bennicelli C., Corbett G.E., Kerger B.D. Estimates of the chromium (VI) reducing capacity in human body compartments as a mechanism for attenuating its potential toxicity and carcinogenicity. Carcinogenesis. 18:1997;531-537.
75. IARC, Nickel and nickel compounds, in: Chromium, Nickel and Welding, Lyon, International Agency for Research on Cancer, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 49, 1990, pp. 257-445.
76. US EPA, Air quality criteria for lead, Environmental Protection Agency, EPA-600/8-83/028aF-dF, Washington, DC, 1886.
77. Bodger P.M., Yess N.J., Gunderson E.L., Troxell T.C., Carrington C.D. Identification and reduction of sources of dietary lead in the United States. Food Addit. Contam. 13:1996;53-60.
78. Baczynskyj W.M., Yess N.J. U.S. Food and drug administration monitoring of lead in domestic and imported ceramic dinner-ware. J. AOAC Int. 78:1995;610-614.
79. Dabeka R.W., McKenzie A.D., Lacroix G.M.A. Dietary intakes of lead, cadmium, arsenic and fluoride by Canadian adults: a 24-hour duplicate diet study. Food Addit. Contam. 4:1987;89-102.
80. D. Worth, A. Matranga, M. Lieberman, E. Devos, P. Karelekas, C. Ryan, G. Kraun, Lead in drinking water, The contribution of household tap water to blood lead levels, in: D.R. Lynam, L.G. Piantanida, J.F. Cole (Eds.), Environmental Lead, Proceedings of the Second International Symposium on Environmental Lead Research, Academic Press, New York, 1981, pp. 199-225.
81. Sherlock J., Smart G., Forbes G.I., Moore M.R., Patterson W.J., Richards W.N., Wilson T.S. Assessment of lead intakes and dose-response for a population in Air exposed to a plumbsolvent water supply. Hum. Toxicol. 1:1982;115-122.
82. Sherlock J.C., Pickford C.J., White G.F. Lead in alcoholic beverages. Food Addit. Contam. 3:1986;347-354.
83. Rossman T.G., Molina M., Meyer L.W. the genetic toxicology of metal compounds: I. Induction of prophage in E. coli WP2s. Environ. Mutagen. 6:1984;59-69.
84. Johnson F.M. The genetic effects of environmental lead. Mutat. Res. 410:1998;123-140.
85. Hayashi M. Lead toxicity in the pregnant rat: II. Effects of low-level lead on δ-aminolevulinic acid dehydratase activity in maternal and fetal blood or tissue. Ind. Health. 21:1983;127-135.
86. Leonard A. Mechanisms in metal genotoxicity: the significance of in vitro approaches. Mutat. Res. 198:1988;321-326.
87. Kasprzak K.S., Hoover K.L., Poirier L.A. Effects of dietary calcium acetate on lead subacetate carcinogenicity in kidneys of male Sprague-Dawley rats. Carcinogenesis. 6:1985;279-282.
88. Koller L.D., Kerkvliet N.I., Exon J.H. Neoplasia induced in male rats fed lead acetate, ethyl urea and sodium nitrate. Toxicol. Pathol. 13:1986;50-57.
89. IARC (International Agency for Research on Cancer), Lead [7439-92-1] and Lead Compounds, Inorganic, IARC Monographs, Lyon, Vol. 23, 1987.
90. Casto B.C., Meyers J., di Paolo J.A. Enhancement of viral transformation for evaluation of the carcinogenic or mutagenic potential of inorganic metal salts. Cancer Res. 39:1979;193-198.
91. WHO, Mercury, IPCS, Environmental Health Criteria 1, World Health Organization Geneva, 1976, p. 131.
92. Inskip M.J., Piotrowski J.K. Review of the health effects of methylmercury. J. Appl. Toxicol. 5:1985;113-133.
93. Cappon C.J., Smith J.C. Chemical form and distribution of mercury and selenium in edible seafood. J. Anal. Toxicol. 6:1995;10-21.
94. WHO, Methylmercury, IPCS, Environmental Health Criteria 101, World Health Organization Geneva, 1990, p. 144.
95. Rossman T.G., Zelikoff J.T., Agarwal S., Kneip T.J. Genetic toxicology of metal compounds: an examination of appropriate cellular models. Toxicol. Environ. Chem. 14:1987;251-262.
96. Klein C.B., Kargacin B., Su L., Cosentino S., Snow E.T., Costa M. Metal mutagenesis in transgenic Chinese hamster cell lines. Environ. Health Perspect. 102:1994;63-67.
97. DeFlora S., Bennicelli C., Bagnasco M. Genotoxicity of mercury compounds. A review. Mutat. Res. 317:1994;57-79.
98. Costa M., Zhitkovich A., Gargas M., Pautenbach D., Finley B., Kuykendall J., Billings R., Carlson T.J., Wetterhahn K., Xu J., Patierno S., Bogdanffy M. Interlaboratory validation of a new assay for DNA-protein crosslinks. Mutat. Res. 369:1996;13-21.
99. Snyder R.D., Lachmann P.J. Thiol involvement in the inhibition of DNA repair by metals in mammalian cells. Mol. Toxicol. 2:1989;117-128.
100. Mabille V., Roels H., Jacquet P., Leonard A., Lauwerys R. Cytogenetic examination of leucocytes of workers exposed to mercury vapour. Int. Arch. Occup. Environ. Health. 53:1984;257-260.
101. Vershaeve L., Kirsch-Volders M., Susanne C. Mercury-induced segregational errors of chromosomes in human lymphocytes and in Indian muntjac cells. Toxicol. Lett. 21:1984;247-253.
102. Mitsumori K., Hirano M., Aleda H., Maita K., Shirasu Y. Chronic toxicity and carcinogenicity of methylmercury chloride in B6C3F1 mice. Fundam. Appl. Toxicol. 14:1990;179-190.
103. IARC, Monographs on the evaluation of the carcinogenic risks on humans, beryllium, cadmium, mercury, and exposures in the glass manufacturing industry, Lyon IARC, 1993.
104. Ahlbom A., Norell S., Nylander M., Rodvall Y. Dentists, dental nurses, and brain tumours. Br. Med. J. 292:1986;662.
105. Spears J.W., Hatfield E.E., Forbes R.M., Koenig S.E. Studies on the role of nickel in the ruminant. J. Nutr. 108:1978;313-320.
106. P. Grandjean, Human exposure to nickel, in: Nickel in the Human Environment. Proceedings of a Joint Symposium, Lyon, 8-11 March, 1983, Lyon, International Agency for Research on Cancer, IARC Scientific Publications No. 53, 1984, pp. 4469-4485.
107. Sen P., Costa M. Induction of chromosomal damage in Chinese hamster ovary cells by soluble and particulate nickel compounds: preferential fragmentation of the heterochromatic long arm of the X-chromosome by carcinogenic cystalline NiS particles. Cancer Res. 45:1985;2320-2325.
108. Kargacin B., Klein C.B., Costa M. Mutagenic responses of nickel oxides and nickel sulfides in Chinese hanster V79 cell lines at the xanthineguanine phosphoribosyl transferase locus. Mutat. Res. 300:1993;63-72.
109. Katsifis S.P., Kinney P.L., Hosselet S., Burns F.J., Christie N.T. Interaction of nickel with mutagens in the induction of sister chromatid exchanges in human lymphocytes. Mutat. Res. 359:1996;7-15.
110. Dubins J.S., LaVelle J.M. Nickel(II) genotoxicity: potentiation of mutagenesis of simple alkylating agents. Mutat. Res. 162:1986;187-199.
111. Hong Y.C., Paik S.R., Lee H.J., Lee K.H., Jang S.M. Magnesium inhibits nickel-induced genotoxicity and formation of reactive oxygen. Environ. Health Perspect. 105:1997;744-7448.
112. Hartwig A., Kruger I., Beyersmann D. Mechanisms in nickel genotoxicity: the significance of interactions with DNA repair. Toxicol. Lett. 72:1994;353-358.
113. Klein C.B., Costa M. DNA methylation, heterochromatin and epigenetic carcinogens. Mutat. Res. 386:1997;163-180.
114. Norseth T. Cancer hazards caused by nickel and chromium exposure. J. Toxicol. Environ. Health. 6:1980;1219-1227.
115. Reith A., Brogger A. Carcinogenicity and mutagenicity of nickel and nickel compounds. IARC Sci. Publ. 53:1984;175-192.
116. 2 formation by human polymorphonuclear leukocytes. Cancer Res. 50:1990;7564-7570.
117. Sakurai H., Tsuchiya K. A tentative recommendation for the maximum daily intake of selenium. Environ. Physiol. Biochem. 5:1975;107-118.
118. Thorn J., Robertson J., Buss D.H. Trace nutrients. Selenium in British food. Br. J. Nutr. 39:1978;391-396.
119. W.G. Jaffe, Effect of selenium intake in humans and in rats, in: Proceedings of the Symposium on Selenium-Tellurium in the Environment, Industrial Health Foundation, Pittsburgh, PA, 1976, pp. 188-193.
120. Moore F.R., Orda G.A., Krishna G., Theiss J.C. Genotoxicity evaluation of selenium sulfade in vivo and in-vivo/in vitro micronucleus and chromosomal aberration assays. Mutat. Res. 367:1996;33-41.
121. Noda M., Takano T., Sakurai H. Mutagenic activity of selenium compounds. Mutat. Res. 66:1979;175-179.
122. Lofroth G., Ames B.N. Mutagenicity of inorganic compounds in Salmonella typhimurium: arsenic, chromium, and selenium. Mutat. Res. 53:1978;65-66.
123. Ray J.H., Altenberg L.C. Sister-chromatid exchange induction by sodium selenite: dependence on the presence of red blood cells or red blood cell lysate. Mutat. Res. 54:1978;343-354.
124. Sirianni S.R., Huang C.C. Induction of sister chromatid exchange by various selenium compounds in Chinese hamster cells in the presence and absence of S9 mixture. Cancer Lett. 18:1983;109-116.
125. Shelby M.D., Witt K.L. Comparison of results from mouse bone marrow C.A. and M.N. tests. Environ. Mol. Mutagen. 25:1995;302-313.
126. Stahl A., Anundi I., Hogberg J. Selenite biotransformation to volatile metabolites in an isolated hapatocyte model system. Biochem. Pharmacol. 33:1984;1111-1117.
127. Martin S.E., Adams G.H., Schillaci M., Milner J.A. Antimutagenic effect of selenium on acridine orange and 7.12-dimethylbenz [α] anthracene in the Ames Salmonella/microsomal system. Mutat. Res. 82:1981;41-46.
128. Shamberger R.J. The genotoxic of selenium. Mutat. Res. 154:1985;29-48.
129. Schroeder H.A., Mitchener M. Selenium and tellurium in mice. Effects on growth, survival and tumors. Arch. Environ. Health. 24:1972;66-71.
130. Shapiro J.R. Selenium and carcinogenesis: a review. Ann. NY Acad. Sci. 192:1972;215-219.
131. NCI (National Cancer Institute), Bioassay of selenium sulfide for possible carcinogenicity (gavage study), Bethesda, Maryland, US Department of Health and Human Services, Public Health Service, National Institutes of Health, DHHS Publication No. (NIH) 80-1750, 1980, pp. 132.
132. Glover J.R. Selenium and its industrial toxicology. Ind. Med. Surg. 39:1970;50-54.
133. -mustards and selenium, Lyons, International Agency for Research on Cancer, (IAR Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man) 9, 1975, 245-260.
134. Whanger P.D. Selenium interactions with carcinogens. Fundam. Appl. Toxicol. 3:1983;424-430.
135. Fishbein L. Perspectives in metal carcinogenesis: I. Selenium. Arch. Geschwulstforsch. 56:1986;53-78.
136. Medina D., Shephard F. Selenium-mediated inhibition of mouse mammary tumorigenesis. Cancer Lett. 8:1980;241-245.
137. Ip C., Sinha D.K. Enhancement of mammary tumorigenesis by dietary selenium deficiency in rats with a high polyunsaturated fat intake. Cancer Res. 41:1981;31-34.
138. WHO, Tin and Organotin Compounds, Environmental Health Criteria 15, World Health Organization Geneva, 1980, p. 109.
139. Nishijima M., Ueda K., Maki T., Wada M., Takahashi S., Kimura Y., Yamada T., Nakajima K., Fukuda T. [Studies on heavy metals dissolved in canned foods. (II) Detection of tin and lead from various canned fruits after their opening]. Ann. Rep. Tokyo Metrop. Inst. Huyg. 23:1971;189-196.
140. Hu G.G. Sister chromatid exchanges (SCE) chromosomal aberrations and micronuclei of cultured peripheral lymphocytes in patients with lung cancer, miners and non-mining workers of the tin mine in Yunnan. Chung Hua Chung Liu Tsa Chih. 9:1987;29-32. Chinese.
141. M. Bernardo-Filho, M. da C. Cunha, I. de O. Valsa, A. C. de Araujo, F.C. da Silva, A. de S. da Fonseca, Evaluation of potential genotoxicity of stannous chloride: inactivation, filamentation and lysogenic induction of Escherichia coli, 1994.
142. Ganguly B.B., Talukdar G., Sharma A. Cytotoxicity of tin on human peripheral lymphocytes in vitro. Mutat. Res. 282:1992;61-67.
143. Walters M., Roe F.J.C. A study on the effects of zinc and tin administered orally to mice over a prolonged period. Food Cosmet. Toxicol. 3:1965;271-276.
144. Roe F.J.C., Boyland E., Millican K. Effects of oral administration of two tin compounds to rats over prolonged periods. Food Cosmet. Toxicol. 3:1965;277-280.
145. Winship K.A. Toxicity of tin and its compounds adverse. Drug React. Acute Poisoning Rev. 7:1988;19-38.
146. Myron D.R., Givand S.H., Nielsen F.H. Vanadium content of selected foods as determined by flameless atomic absorption spectroscopy. J. Agric. Food Chem. 25:1977;297-299.
147. Byrne A.R., Costa L. Vanadium in foods and in human body fluids and tissues. Sci. Total Environ. 10:1978;17-30.
148. Söremark R. Vanadium in some biological specimens. J. Nutr. 92:1967;183-190.
149. Myron D.R., Zimmerman T.J., Shuler T.R., Klevay L.M., Lee D.E., Nielsen F.H. Intake of nickel and vanadium by humans. A survey of selected diets. Am. J. Clin. Nutr. 31:1978;527-531.
150. WHO, Vanadio, IPCS, Environmental Health Criteria 81, World Health Organization Geneva, 1988, p. 170.
151. J. Kucera, E. Sabbioni, Baseline vanadium levels in human blood, serum, and urine, Vanadium in the Environment, Part Two, Health Effects, in: J.O. Nriagu (Ed.), Advances in Environmental Science and Technology, Wiley Series, Vol. 31, 1998.
152. M. Altamirano-Lozano, E. Roldan-Reyes, E. Rojas, Genetic toxicology of vanadium compounds, Vanadium in the Environment, Parts I and II, Wiley, 1997.
153. Altamirano-Lozano M., Alvarez-Barrera L., Basurto-Alcantara F., Valverde M., Rojas E. Reprotoxic and gneotoxicstudies of vanadium pentoxide in mile mice. Teratogenesis, Carcinogenesis and Mutagenesis. 16:1996;7-17.
154. Rojas E., Valverde M., Altamirano-Lozano M., Ostrosky-Wegman P. Genotoxicity of vanadium pentoxide evaluate by the single cell gel electrophoresis assay in human lymphocytes. Mutat. Res. 359:1996;77-84.
155. Roldan R.E., Altamirano L.M.A. Chromosomal aberrations, sister chromatid exchanges, cell-cycle kinetics and satellite associations in human lymphocyte cultures exposed to vanadium pentoxide. Mutat. Res. 245:1990;61-65.
156. Ramírez R., Eastmond D.A., Laclette J.P., Ostrosky-Wegman P. Disruption of microtubule assembly and spindle formation as a mechanism for the induction of aneuploid cells by sodium arsenite and vanadium pentoxide. Mutat. Res. 386:1997;291-298.
157. Levy B.S., Hoffman L., Gottsegen S. Boilermakers' bronchitis: respiratory tract irritation associated with vanadium pentoxide exposure during oil-to-coal conversion of a power plant. J. Occup. Med. 26:1984;567-570.
158. Kingsnorth A.N., Lamuraglia G.M., Ross J.S., Malt R.A. Vanadate supplements and 1, 2-dimethylhydrzine induced colon cancer in mice: increased thymidine incorporation without enhanced carcinogenesis. Br. J. Cancer. 53:1986;386-683.
159. Kerckaert G.A., LeBoeuf R.A., Isfort R.J. Use of the Syrian hamster embryo cell transformation assay for determining the carcinogenic potential of heavy metal compounds. Fundam. Appl. Toxicol. 34:1996;67-72.
160. Lewis D.F., Ioannides C., Parke D.V. COMPACT and molecular structure in toxicity assessment: a prospective evaluation of 30 chemicals currently being tested for rodent carcinogenicity by the NCI/NTP. Environ. Health Perspect. 104:1996;1011-1016.
161. Ames B.N., Gold L.S. Too many rodent carcinogens: mitogenesis increases mutagenesis. Science. 249:1990;970-971.
162. Todd W., Elvejehm C.A., Hart E. Zinc in the nutrition of the rat. Am. J. Physiol. 107:1934;146-153.
163. Riordan J.F. Biochemistry of zinc. Med. Clin. North Am. 60:1976;661-674.
164. Barch D.H., Iannaccone P.M. Role of zinc deficiency in carcinogenesis. Adv. Exp. Med. Biol. 206:1986;517-527.
165. Kasprzak K.S., Waalkes M.P. The role of calcium, magnesium, and zinc in carcinogenesis. Adv. Exp. Med. Biol. 206:1986;497-515.
166. Prasad A.S. The role of zinc in gastrointestinal and liver disease. Clin. Gastroenterol. 12:1983;713-741.
167. Leonard A., Gerber G.B., Leonard F. Mutagenicity, carcinogenicity and teratogenicity of zinc. Mutat. Res. 168:1986;343-353.
168. Thompson E.D., McDermott J.A., Zerkle T.B., Skare J.A., Evans B.L., Cody D.B. Genotoxicity of zinc in 4 short-term mutagenicity assays. Mutat. Res. 223:1989;267-272.
169. N.P. Skoulis, S.J. Barbee, D. Jacobson-Kram, D.L. Putman, R.H. San, Evaluation of the genotoxic potential of zinc pyrithione in the Salmonella mutagenicity (Ames) assay, CHO/HGPRT gene mutation assay and mouse micronucleus assay.
170. Codina J.C., Perez-Torrente C., Perez-Garcia A., Cazorla F.M., de Vicente A. Comparison of microbial tests for the detection of heavy metal genotoxicity. Arch. Environ. Contam. Toxicol. 29:1995;260-265.
171. Goncharova E.I., Rossman T.G. A role for metallothionein and zinc in spontaneous mutagenesis. Cancer Res. 54:1994;5138-5323.
172. Ogawa H.I., Shibahara T., Iwata H., Okada T., Tsuruta S., Kakimoto K., Sakata K., Kato Y., Ryo H., Itoh T. Genotoxic activities in vivo of cobaltous chloride and other metal chlorides as assayed in the Drosophila wing spot test. Mutat. Res. 320:1994;133-140.
173. Kim R.H., Lee S.M., Park J.W. Enhancement by copper, zinc superoxide dismutase of DNA damage and mutagenicity with hydrogen peroxide. Biochem. Mol. Biol. Int. 45:1998;635-642.
174. L.A. Poirier, N.A. Littlefield, Metal interactions in chemical carcinogenesis, in: L. Chang (Ed.), Toxicology of Metals, Lewis Publishers, New York, 1996, pp. 289-298.
175. Kasprzak K.S., Kovatch R.M., Poirier L.A. Inhibitory effect of zinc on nickel subsulfide carcinogenesis in Fischer rats. Toxicology. 52:1988;253-262.
176. Waalkes M.P., Kovatch R., Rehm S. Effect of chronic dietary zinc deficiency on cadmium toxicity and carcinogenesis in the male Wistar [Hsd: (WI)BR] rat. Toxicol. Appl. Pharmacol. 108:1991;448-456.
177. Newberne P.M., Schrager T.F., Broitman S. Esophageal carcinogenesis in the rat: zinc deficiency and alcohol effects on tumor induction. Pathobiology. 65:1997;39-45.
178. Newberne P.M., Broitman S., Schrager T.F. Esophageal carcinogenesis in the rat: zinc deficiency, DNA methylation and alkyltransferase activity. Pathobiology. 65:1997;253-263.
179. Waalkes M.P., Rehm S. Carcinogenicity of oral cadmium in the male Wistar (WF/NCr) rat: effect of. Fundam. Appl. Toxicol. 19:1992;512-520.
180. Zhao C.Q., Young M.R., Diwan B.A., Coogan T.P., Waalkes M.P. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc. Natl. Acad. Sci. U.S.A. 94:1997;10907-10912.
181. Mass M.J., Wang L. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat. Res. 386:1997;263-277.
182. Healy S.M., Casarez E.A., Ayala-Fierro F., Aposhian H. Enzymatic methylation of arsenic compounds. V. Arsenite methyltransferase activity in tissues of mice. Toxicol. Appl. Pharmacol. 148:1998;65-70.
183. Costa M. Model for the epigenetic mechanism of action of nongenotoxic carcinogens. Am. J. Clin. Nutr. 61:1995;666S-669S.
184. Salnikow K., Wang S., Costa M. Induction of activating transcription factor 1 by nickel and its role as a negative regulator of thrombospondin I gene expression. Cancer Res. 57:1997;5060-5066.
185. Rossiello M.R., Aresta A.M., Prisco M., Kanduc D. DNA hypomethylation during liver cell proliferation induced by a single dose of lead nitrate. [LUIS: This reference may be added to the next one on Pb producing hypomethylation in rat liver.]. Boll. Soc. Ital. Biol. Sper. 67:1991;993-997.
186. Kanduc D., Rossiello M.R., Aresta A., Cavazza C., Quagliariello E., Farber E. Transitory DNA hypomethylation during liver cell proliferation induced by a single dose of lead nitrate. Arch. Biochem. Biophys. 286:1991;212-216.
187. Waalkes M.P., Wilson M.J., Poirier A. Reduced cadmium-induced cytotoxicity in cultured liver cells following 5-azacytidine pretreatment. Toxicol. Appl. Pharmacol. 81:1985;250-257.
188. Waalkes M.P., Wilson M.J. Enhancement of cadmium-induced metallothionein synthesis in cultured TRL 1215 cells by butyric acid pretreatment. Toxicol. Lett. 32:1986;289-294.
189. Waalkes M.P., Miller M.S., Wilson M.J., Bare R.M., McDowell A.E. Increased metallothionein gene expression in 5-aza-2′-deoxycytidine-induced resistance to cadmium cytotoxicity. Chem. Biol. Interact. 66:1988;189-204.
190. Cox R., Goorha S. A study of the mechanism of selenite-induced hypomethylated DNA and differentiation of Friend erythroleukemic cells. Carcinogenesis. 7:1986;2015-2018.
191. Hoffman J.L., McConnell K.P. Periodate-oxidized adenosine inhibits the formation of dimethylselenide and trimethylselenonium ion in mice treated with selenite. Arch. Biochem. Biophys. 254:1987;534-540.
192. Fiala E.S., Staretz M.E., Pandya G.A., El-Bayoumy K., Hamilton S.R. Inhibition of DNA cytosine methyltransferase by chemopreventive selenium compounds, determined by an improved assay for DNA cytosine methyltransferase and DNA cytosine methylation. Carcinogenesis. 19:1998;597-604.
193. Duerre J.A., Wallwork J.C. Methionine metabolism in isolated perfused livers from rats fed on zinc-deficient and restricted diets. Br. J. Nutr. 56:1986;395-405.
194. Lyn-Cook B.D., Wise C.W., Patterson T., Blann E., Green B., Poirier L.A., Slikker W. Micronutrient regulation of S-adenosylmethionine levels in transformed pancreatic cells in vitro. Proc. Am. Assoc. Cancer Res. 39:1998;118.
195. Bestor T.H. Activation of mammalian DNA methyltransferase by cleavage of a Zn binding regulatory domain. EMBO J. 11:1992;2611-2617.
196. K. Kasprzak, Oxidative damage in metal-induced carcinogenesis, in: L. Chang (Ed.), Toxicology of Metals, Chap. 18, Lewis Publishers, New York, 1996, pp. 299-320.
197. Adams S.P., Laws G.M., Storer R.D., DeLuca J.G., Nichols W.W. Detection of DNA damage induced by human carcinogens in acellular assays: potential application for determining genotoxic mechanisms. Mutat. Res. 368:1996;235-248.
198. Mikhailova M.V., Littlefield N.A., Hass B.S., Poirier L.A., Chou M.W. Cadmium-induced 8-hydroxydeoxyguanosine formation, DNA strand breaks and antioxidant enzyme activities in lymphoblastoid cells. Cancer Lett. 19:1997;141-148.
199. Ogura H., Takeuchi T., Morimoto K. A comparison of the 8-hydroxydeoxyguanosine, chromosome aberrations and micronucleus techniques for the assessment of the genotoxicity of mercury compounds in human blood lymphocytes. Mutat. Res. 340:1996;175-182.
200. Shi X., Jiang H., Mao Y., Ye J., Saffiotti U. Vanadium(IV)-mediated free radical generation and related 2′-deoxyguanosine hydroxylation and DNA damage. Toxicology. 106:1996;27-38.
201. Lloyd D.R., Carmichael P.L., Phillips D.H. Comparison of the formation of 8-hydroxy-2′-deoxyguanosine and single- and double-strand breaks in DNA mediated by fenton reactions. Chem. Res. Toxicol. 11:1998;420-427.
202. Zhizhina G.P., Blyukhterova N.V. Effect of metal ions and xenobiotics on endogenous oxidation of DNA. Biochemistry (Mosc.). 62:1997;88-94.
203. Haegele A.D., Briggs S.P., Thompson H.J. Antioxidant status and dietary lipid unsaturation modulate oxidative DNA damage. Free Radic. Biol. Med. 16:1994;111-115.
204. Shen H.M., Ong C.N., Lee B.L., Shi C.Y. Aflatoxin B1-induced 8-hydroxydeoxyguanosine formation in rat hepatic DNA. Carcinogenesis. 16:1995;419-422.
205. Olin K.L., Shigenaga M.K., Ames B.N., Golub M.S., Gershwin M.E., Hendrickx A.G., Keen C.L. Maternal dietary zinc influences DNA strand break and 8-hydroxy-2′-deoxyguanosine levels in infant rhesus monkey liver. Proc. Soc. Exp. Biol. Med. 203(4):1993;461-466.
206. L.A. Poirier, Selected concepts in metal carcinogenesis, in: L. Chang (Ed.), Toxicology of Metals, Ch. Lewis Publishers, New York, Vol. 17, 1996, pp. 289-298.
207. Gupta P., Kar A. Role of ascorbic acid in cadmium-induced thyroid dysfunction and lipid peroxidation. J. Appl. Toxicol. 8:1998;317-320.
208. Sarkar S., Yadav P., Bhatnagar D. Lipid peroxidative damage on cadmium exposure and alterations in antioxidant system in rat erythrocytes: a study with relation to time. Biometals. 11:1998;153-157.
209. Andersen H.R., Andersen O. Effect of cadmium chloride on hepatic lipid peroxidation in mice. Pharmacol. Toxicol. 63:1988;173-177.
210. Yang C.F., Shen H.M., Shen Y., Zhuang Z.X., Ong C.N. Cadmium-induced oxidative cellular damage in human fetal lung fibroblasts (MRC-5 cells). Environ. Health Perspect. 105:1997;712-716.
211. Yang J.L., Chao J.I., Lin J.G. Reactive oxygen species may participate in the mutagenicity. Chem. Res. Toxicol. 9:1996;1360-1367.
212. Bagchi D., Hassoun E.A., Bagchi M., Stohs S.J. Chromium-induced excretion of urinary lipid metabolites, DNA damage, nitric oxide production, and generation of reactive oxygen species in Sprague-Dawley rats. Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol. 110:1995;177-187.
213. Susa N., Ueno S., Furukawa Y., Sugiyama M. Protective effect of vitamin E on chromium (VI)-induced cytotoxicity and lipid peroxidation in primary cultures of rat hepatocytes. Arch. Toxicol. 71:1996;20-24.
214. Susa N., Ueno S., Furukawa Y., Ueda J., Sugiyama M. Potent protective effect of melatonin on chromium(VI)-induced DNA single-strand breaks, cytotoxicity, and lipid peroxidation in primary cultures of rat hepatocytes. Toxicol. Appl. Pharmacol. 144:1997;377-484.
215. Susa N., Ueno S., Furukawa Y. Protective effect of diethyldithiocarbamate pretreatment on chromium (VI)-induced cytotoxicity and lipid peroxidation in primary cultures of rat hepatocytes. J. Vet. Med. Sci. 60:1998;71-76.
216. Sugiyama M. Role of physiological antioxidants in chromium(VI)-induced cellular injury. Free Radic. Biol. Med. 12:1992;397-407.
217. Susa N., Ueno S., Furukawa Y., Michiba N., Minoura S. Induction of lipid peroxidation in mice by hexavalent chromium and its relation to the toxicity. Nippon Juigaku Zasshi. 51:1989;1103-1110.
218. Chen C.Y., Huang Y.L., Lin T.H. Effects of vitamin A pretreatment on nickel-induced lipid peroxidation and concentration of essential metals in liver, kidney and lung of mice. Arch. Toxicol. 72(6):1998;381-386.
219. Savolainen H. Biochemical and clinical aspects of nickel toxicity. Rev. Environ. Health. 11:1996;167-173.
220. Lawton L.J., Donaldson W.E. Lead-induced tissue fatty acid alterations and lipid peroxidation. Biol. Trace Elem. Res. 28:1991;83-97.
221. Hsu P.C., Liu M.Y., Hsu C.C., Chen L.Y., Guo Y.L. Effects of vitamin E and/or C on reactive oxygen species-related lead toxicity in the rat sperm. Toxicology. 128:1998;169-179.
222. Ramos O., Carrizales L., Yanez L., Mejia J., Batres L., Ortiz D., Diaz-Barriga F. Arsenic increased lipid peroxidation in rat tissues by a mechanism independent of glutathione levels. Environ. Health Perspect. 103:1995;85-88.
223. Huang Y.L., Cheng S.L., Lin T.H. Lipid peroxidation in rats administrated with mercuric chloride. Biol. Trace Elem. Res. 52:1996;193-206.
224. Donaldson J., Hemming R., LaBella F. Vanadium exposure enhances lipid peroxidation in the kidney of rats and mice. Can. J. Physiol. Pharmacol. 63:1985;196-199.
225. Pironi L., Ruggeri E., Zolezzi C., Savarino L., Incasa E., Belluzzi A., Munarini A., Piazzi S., Tolomelli M., Pizzoferrato A., Miglioli M. Lipid peroxidation and antioxidant status in adults receiving lipid-based home parenteral nutrition. Am. J. Clin. Nutr. 68:1998;888-893.
226. Stohs S.J., Al-Bayati Z.F., Hassan M.Q., Murray W.J., Mohammadpour H.A. Glutathione peroxidase and reactive oxygen species in TCDD-induced lipid peroxidation. Adv. Exp. Med. Biol. 197:1986;357-365.
227. Ozolins T.R., Siksay D.L., Wells P.G. Modulation of embryonic glutathione peroxidase activity and phenytoin teratogenicity by dietary deprivation of selenium in CD-1 mice. J. Pharmacol. Exp. Ther. 277:1996;945-953.
228. Othman A.I., el Missiry M.A. Role of selenium against lead toxicity in male rats. J. Biochem. Mol. Toxicol. 12:1998;345-349.
229. Medina D. Mechanisms of selenium inhibition of tumorigenesis. Adv. Exp. Med. Biol. 206:1986;465-472.
230. Sullivan J.F., Jetton M.M., Hahn H.K., Burch E. Enhanced lipid peroxidation in liver microsomes of zinc-deficient rats. Am. J. Clin. Nutr. 33:1980;51-56.
231. Cao G.H., Chen J.D. Effects of dietary zinc on free radical generation, lipid peroxidation, and superoxide dismutase in trained mice. Arch. Biochem. Biophys. 291:1991;147-153.
232. Faure P., Benhamou P.Y., Perard A., Halimi S., Roussel A.M. Lipid peroxidation in insulin-dependent diabetic patients with early retina degenerative lesions: effects of an oral zinc supplementation. Eur. J. Clin. Nutr. 49:1995;282-288.
233. 2) increases the steady-state mRNA levels of collagenase/MMP-1 in human dermal fibroblasts. Free Radic. Biol. Med. 22:1997;515-524.
234. el Ghissassi F., Barbin A., Nair J., Bartsch H. Formation of 1,N6-ethenoadenine and 3,N4-ethenocytosine by lipid peroxidation products and nucleic acid bases. Chem. Res. Toxicol. 8:1995;278-283.
235. Nair J., Sone H., Nagao M., Barbin A., Bartsch H. Copper-dependent formation of miscoding etheno-DNA adducts in the liver of Long Evans cinnamon (LEC) rats developing hereditary hepatitis and hepatocellular carcinoma. Cancer Res. 56:1996;1267-1271.
236. Nair J., Carmichael P.L., Fernando R.C., Phillips D.H., Strain A.J., Bartsch H. Lipid peroxidation-induced etheno-DNA adducts in the liver of patients with the genetic metal storage disorders Wilson's disease and primary hemochromatosis. Cancer Epidemiol. Biomarkers Prev. 7:1998;435-440.
237. 31P nuclear magnetic resonance studies of arsenite induced changes in hepatic phosphate levels Biochem. Biophys. Res. Commun. 139:1986;228-234.
238. Hartwig A. Role of DNA repair inhibition in lead- and cadmium-induced genotoxicity: a review. Environ. Health Perspect. 102:1994;45-50.
239. A. Furst, Metal interactions in carcinogenesis, in: L. Fishbein, A. Furst, M.A. Mehlman (Eds.), Genotoxic and Carcinogenic Metals: Environmental and Occupational Occurrence and Exposure, Princeton Scientific Publishing, 1987, pp. 279-294.
240. Hartwig A., Mullenders L.H., Schlepegrell R., Kasten U., Beyersmann D. Nickel(II) interferes with the incision step in nucleotide excision repair in mammalian cells. Cancer Res. 54:1994;4045-4051.
241. Simons T.J.B., Pocock G. Lead enters adrenal medullary cells through calcium channels. J. Neurochem. 48:1987;383-389.
242. Chai S., Webb R.C. Effects of lead on vascular reactivity. Environ. Health Perspect. 78:1988;85-90.
243. Parizck J., Ostadolova I. The protective effect of small amounts of selenite in sublimate intoxication. Experientia. 23:1967;142-143.
244. Ganther H.E. Modification of methylmercury toxicity and metabolism by vitamin E and selenium. Environ. Health Perspect. 25:1978;71-76.
245. Ganther H.E., Sunde M.L. Effect of tuna fish and selenium on the toxicity of methylmercury: a progress report. J. Food Sci. 39:1974;1-5.
246. Schrauzer G.N., White D., McGTinnes J.E., Schneider C.J., Bell L.J. Arsenic and cancer: effects of joint administration of arsenite and selenite on the genesis of mammary adenocarcinoma in inbread female C3H/Sr mice. Bioinorg. Chem. 9:1978;245-253.
247. Tice R.R., Yager J.W., Andrews P., Crecelius E. Effect of hepatic methyl donor status on urinary excretion and DNA damage in B6C3F1 mice treated with sodium arsenite. Mutat. Res. 386:1997;315-334.
248. Chiou H.-Y., Hsueh Y.-M., Hsieh L.-L., Hsu L.-I., Hsu Y.-H., Hsieh F.-I., Wei J.-L., Chen H.-C., Yang H.-T., Leu L.-C., Chu T.-H., Chen-Wu C., Yang M.-H., Chen C.-J. Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mutat. Res. 386:1997;197-207.
249. Alexander B.H., Checkoway H., Costa-Mallen P., Faustman E.M., Woods J.S., Kelsey K.T., van Netten C., Costa L.G. Interaction of blood lead and δ-aminolevulinic acid dehydratase genotype on markers of heme synthesis and sperm production in lead smelter workers. Environ. Health Perspect. 106:1998;213-216.
250. U.S. EPA IRIS substance file 278, Arsenic, Inorganic, Office of Risk Information Systems, EPA, Washington, DC, 1993.
251. U.S. EPA IRIS substance file 141, Cadmium, Office of Risk Information Systems, EPA, Washington, DC, 1997.
252. U.S. EPA IRIS substance file 144, Chromium (VI), Office of Risk Information Systems, EPA, Washington, DC, 1998.
253. U.S. EPA IRIS substance file 271, Nickel, Soluble Salts, Office of Risk Information Systems, EPA, Washington, DC, 1998.
254. U.S. EPA IRIS substance file 277, Lead and Compounds (Inorganic), Office of Risk Information Systems, EPA, Washington, DC, 1997.
255. U.S. EPA Office of Water, Arsenic in Drinking Water, Office of Ground Water and Drinking Water, EPA, Washington, DC, 1997.
256. Bogden J.D., Gertner S.B., Kemp F.W., McLeod R., Bruening K.S., Chung H.R. Dietary lead and calcium: effects on blood pressure and renal neoplasia in Wistar rats. J. Nutr. 121:1991;718-728.
257. Stohrer G. Arsenic: opportunity for risk assessment. Arch. Toxicol. 65:1991;525-531.
258. Mushak P., Crocetti A.F. Risk and revisionism in arsenic cancer risk assessment. Environ. Health Perspect. 103:1995;684-689.
259. Byrd D.M., Roegner M.L., Griffiths J.C., Lamm S.H., Grumski K.S., Wilson R., Lai S. Carcinogenic risks of inorganic arsenic in perspective. Int. Arch. Occup. Environ. Health. 68:1996;484-494.
260. Schroeder H.A., Balassa J.J., Tipton I.H. Abnormal trace metals in man. Tin. J. Chron. Dis. 17:1964;483-502.
261. Sola S., Barrio T., Martin A. Essential elements (Mn, Fe, Cu, Zn) in pork and duck liver paste produced in Spain. Food Addit. Contam. 14:1997;135-141.
262. Mares-Perlman J.A., Subar A.F., Block G., Greger J.L., Luby M.H. Zinc intake and sources in the US adult population: 1976-1980. J. Am. Coll. Nutr. 14:1995;349-357.